Literature DB >> 12110019

Renal dysfunction in allogeneic hematopoietic cell transplantation.

Chirag R Parikh1, Peter A McSweeney, Didem Korular, Tevfik Ecder, Aicha Merouani, Jeremy Taylor, Vicki Slat-Vasquez, Elizabeth J Shpall, Roy B Jones, Scott I Bearman, Robert W Schrier.   

Abstract

BACKGROUND: Allogeneic hematopoietic cell transplantation (HCT), formerly called bone marrow transplantation, can potentially cure various malignant and non-malignant diseases, but it is associated with a high risk of toxicity. We have previously shown an overall 21% incidence of severe acute renal failure in patients undergoing autologous HCT. The present study evaluated renal dysfunction in patients undergoing allogeneic HCT.
METHODS: The clinical course of 88 adult patients who received allogeneic HCT at the University of Colorado Health Science Center was analyzed. Renal dysfunction was classified as follows: Grade 0 = normal renal function; Grade 1 =>25% decrement in GFR but <twofold rise in serum creatinine; Grade 2 =>twofold increase in serum creatinine; Grade 3 =>twofold increase in serum creatinine and need for dialysis.
RESULTS: Of the 88 patients, 81 (92%) patients had some degree of renal dysfunction (Grade 1, 20 patients; Grade 2, 32 patients; Grade 3, 29 patients). Severe nephrotoxicity (Grade 2 and Grade 3 renal dysfunction) was associated with significantly higher frequencies of sepsis, hepatic toxicity and hepatic veno-occlusive disease (VOD), and lung toxicity. The overall mortality rate at the end of 6 months was 58%. Grade 3 renal dysfunction was associated with a significantly increased risk of mortality (82.6%).
CONCLUSION: A 92% incidence of renal dysfunction in allogeneic HCT patients was found. Lung and liver toxicities were significantly correlated with developing renal dysfunction, and the mortality rates for patients with Grade 3 renal failure exceeded 80%.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110019     DOI: 10.1046/j.1523-1755.2002.00455.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

1.  Cancer therapy and renal injury.

Authors:  Robert W Schrier
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 2.  Acute kidney injury in hematopoietic cell transplantation.

Authors:  Amy Kogon; Sangeeta Hingorani
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

3.  Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy.

Authors:  Ana Andres-Hernando; Belda Dursun; Christopher Altmann; Nilesh Ahuja; Zhibin He; Rhea Bhargava; Charles E Edelstein; Alkesh Jani; Thomas S Hoke; Christina Klein; Sarah Faubel
Journal:  Nephrol Dial Transplant       Date:  2012-07-09       Impact factor: 5.992

Review 4.  Acute kidney injury in HCT: an update.

Authors:  J A Lopes; S Jorge; M Neves
Journal:  Bone Marrow Transplant       Date:  2016-02-08       Impact factor: 5.483

5.  A young woman with oedema.

Authors:  Elena Lazzeri; Giuseppe Stefano Netti; Benedetta Mazzinghi; Calogero Cirami; Maurizio Salvadori; Paola Romagnani
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 6.  Onco-nephrology: AKI in the cancer patient.

Authors:  Albert Q Lam; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

Review 7.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

Review 8.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

9.  Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence.

Authors:  Jun Chen; Houwei Li; Francesco Addabbo; Fung Zhang; Edward Pelger; Daniel Patschan; Hyeong-Cheon Park; Mei-Chuan Kuo; Jei Ni; Glenda Gobe; Praveen N Chander; Alberto Nasjletti; Michael S Goligorsky
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 10.  Renal function following hematological stem cell transplantation in childhood.

Authors:  Ludwig Patzer; Karim Kentouche; Felix Ringelmann; Joachim Misselwitz
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.